The primary cancer type associated with colibactin is colorectal cancer. Studies have shown that individuals with a higher abundance of colibactin-producing E. coli in their gut microbiota have an increased risk of developing this type of cancer. There is also emerging evidence suggesting a possible link to other cancers, such as liver and bladder cancer, although more research is needed to confirm these associations.
